Scilife is an emerging name in the Pharmaceutical Industry and our vision is to evolve into a major player in the Branded Generic Pharmaceutical Segments. We at Scilife believe in the core values of integrity, work passion, respect and caring for the people whose lives we touch – our colleagues, distributors, customers, principals and the community at large.
The manufacturing facility of Scilife has been commissioned after due validation by DRAP. This state-of-the-art facility has been designed to meet all the latest cGMP standards.
Scilife’s State-of-the-Art, manufacturing facility is designed to meet cGMP & WHO guidelines. Special consideration is given to the best manufacturing practices aligned with the prescribed HSE (Health, Safety & Environment) protocols.
Scilife Pharma is focusing on branded generic Pharmaceuticals having a robust and comprehensive Quality Management System (QMS) in place. Our aim is to provide Quality Medicines to the patients in compliance with all internationally accepted good practices.
A dedicated, fully equipped, R&D Department for product development is a special feature of this facility, having leading-edge technology. This will ensure efficacy & stability of the products to meet and exceed the required Quality standards.
Independent Quality Assurance, Validation and Quality Control departments ensure product quality by providing uncompromised quality compliance at all stages of production.
Scilife Pharma’s facility has value-addition of qualified, experienced and competent professionals focusing on development, implementation of cGMP practices and continual improvement in all aspects of manufacturing.
diabetes, neurology, cardiology, gastroenterology, hepatology, ent, infectious diseases, pulmonology, gynecology, endocrinology